Volume 10 Issue 1
Jan.  2019
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2019  >  10(1): 88-90
Ju Chunrong, Wei Bing, Lian Qiaoyan, et al. Prevention and treatment strategy of cytomegalovirus pneumonia after solid organ transplantation: interpretation of the diagnosis and treatment of ATS cytomegalovirus pneumonia[J]. ORGAN TRANSPLANTATION, 2019, 10(1): 88-90. doi: 10.3969/j.issn.1674-7445.2019.01.014
Citation: Ju Chunrong, Wei Bing, Lian Qiaoyan, et al. Prevention and treatment strategy of cytomegalovirus pneumonia after solid organ transplantation: interpretation of the diagnosis and treatment of ATS cytomegalovirus pneumonia[J]. ORGAN TRANSPLANTATION, 2019, 10(1): 88-90. doi: 10.3969/j.issn.1674-7445.2019.01.014
shu

Prevention and treatment strategy of cytomegalovirus pneumonia after solid organ transplantation: interpretation of the diagnosis and treatment of ATS cytomegalovirus pneumonia

doi: 10.3969/j.issn.1674-7445.2019.01.014
  • Received Date: 2018-10-18
    Available Online: 2021-01-19
  • Publish Date: 2019-01-15
    Abstract
    • FullText(HTML)
  • loading
    • References(18)
  • [1]
    BEAM E, RAZONABLE RR. Cytomegalovirus in solid organ transplantation: epidemiology, prevention, and treatment[J]. Curr Infect Dis Rep, 2012, 14(6):633-641. DOI: 10.1007/s11908-012-0292-2.
    [2]
    白纪民, 李浩, 张晓明, 等.肾移植术后巨细胞病毒感染的危险因素分析和血清甘露聚糖结合凝集素的预测价值[J].器官移植, 2013, 4(2):79-83. DOI: 10.3969/j.issn.1674-7445.2013.02.004.

    BAI JM, LI H, ZHANG XM, et al. Risk factors of cytomegalovirus infection and the predictive value of mannose-binding lectin after renal transplantation[J]. Organ Transplant, 2013, 4(2):79-83. DOI: 10.3969/j.issn.1674-7445.2013.02.004.
    [3]
    HALLECK F, KHADZHYNOV D, SCHREZENMEIER E, et al. Prolonged low-dose prophylaxis with valganciclovir in cytomegalovirus-negative recipients of kidney transplants from cytomegalovirus-positive donors allows seroconversion and prevents cytomegalovirus disease[J]. Transplant Proc, 2017, 49(10):2280-2284. DOI: 10.1016/j.transproceed.2017.10.0 04.
    [4]
    MEESING A, RAZONABLE RR. Pharmacologic and immunologic management of cytomegalovirus infection after solid organ and hematopoietic stem cell transplantation[J]. Expert Rev Clin Pharmacol, 2018, 11(8):773-788. DOI: 10.1080/17512433.2018.1501557.
    [5]
    STRUEBER M, WARNECKE G, FUGE J, et al. Everolimus versus mycophenolate mofetil de novo after lung transplantation: a prospective, randomized, open-label trial[J]. Am J Transplant, 2016, 16(11):3171-3180. DOI: 10.1111/ajt.13835.
    [6]
    KOTTON CN, KUMAR D, CALIENDO AM, et al. Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation[J]. Transplantation, 2013, 96(4):333-360. DOI: 10.1097/TP.0b013e31829df29d.
    [7]
    BEAM E, GERMER JJ, LAHR B, et al. Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia[J]. Clin Transplant, 2018, 32(1). DOI: 10.1111/ctr.13149.
    [8]
    KOTTON CN, KUMAR D, CALIENDO AM, et al. The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation[J]. Transplantation, 2018, 102(6):900-931. DOI: 10.1097/TP.0000000000002191.
    [9]
    HUMAR A, LIMAYE AP, BLUMBERG EA, et al. Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study[J]. Transplantation, 2010, 90(12):1427-1431. doi: 10.1097/TP.0b013e3181ff1493
    [10]
    WⅡTA AP, ROUBINIAN N, KHAN Y, et al. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis[J]. Transpl Infect Dis, 2012, 14(3):248-258. DOI: 10.1111/j.1399-3062.2012.00723.x.
    [11]
    AVERY RK, ARAV-BOGER R, MARR KA, et al. Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection[J]. Transplantation, 2016, 100(10):e74-e80. DOI: 10.1097/TP.0000000000001418.
    [12]
    LITJENS NHR, VAN DER WAGEN L, KUBALL J, et al. Potential beneficial effects of cytomegalovirus infection after transplantation[J]. Front Immunol, 2018, 9:389. DOI: 10.3389/fimmu.2018.00389.
    [13]
    LISBOA LF, PREIKSAITIS JK, HUMAR A, et al. Clinical utility of molecular surveillance for cytomegalovirus after antiviral prophylaxis in high-risk solid organ transplant recipients[J]. Transplantation, 2011, 92(9):1063-1068. DOI: 10.1097/TP.0b013e31822fa4b7.
    [14]
    BRUMINHENT J, ROTJANAPAN P, WATCHARANANAN SP. Epidemiologyand outcome of ganciclovir-resistant cytomegalovirus infection after solid organ transplantation: a single transplant center experience in Thailand[J]. Transplant Proc, 2017, 49(5):1048-1052. DOI: 10.1016/j.transproceed.2017.03.053.
    [15]
    KOVAL CE. Prevention and treatment of cytomegalovirus infections in solid organ transplant recipients[J]. Infect Dis Clin North Am, 2018, 32(3):581-597. DOI: 10.1016/j.idc.2018.04.008.
    [16]
    ROLLING KE, JORGENSON MR, DESCOUROUEZ JL, et al. Ganciclovir-resistant cytomegalovirus infection in abdominal solid organ transplant recipients: case series and review of the literature[J]. Pharmacotherapy, 2017, 37(10):1258-1271. DOI: 10.1002/phar.1987.
    [17]
    KAUL DR, STOELBEN S, COBER E, et al. First report of successful treatment of multidrug-resistant cytomegalovirus disease with the novel anti-CMV compound AIC246[J]. Am J Transplant, 2011, 11(5):1079-1084. DOI: 10.1111/j.1600-6143.2011.03530.x.
    [18]
    GRIFFITHS PD, STANTON A, MCCARRELL E, et al. Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial[J]. Lancet, 2011, 377(9773):1256-1263. DOI: 10.1016/S0140-6736(11)60136-0.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (234) PDF downloads(37) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return